Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Allergy to blood group antibody D |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hepatitis B immunoglobulin allergy |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to tetanus immunoglobulin |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to Varicella-zoster virus antibody |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Immunoglobulin product overdose |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Gamma globulin overdose |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental gamma globulin overdose |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Intentional gamma globulin overdose |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Gamma globulin overdose of undetermined intent |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Poisoning caused by gamma globulin |
Causative agent (attribute) |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing immunoglobulin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing human immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 250mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 750mg injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 10g intravenous infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 6g infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 5g infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 3g infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 2.5g infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 1g intravenous infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 500mg intravenous infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 16% injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Specific immunoglobulins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-hbs immunoglobulin injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
poudre de 1000 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
poudre de 200 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
poudre de 500 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rubella immunoglobulin 25,000iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing human tick borne encephalitis immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Normal immunoglobulin (2) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 12g intravenous infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Immune globulin IV (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
agent immunobiologique disponible auprès des Centres for Disease Control and Prevention |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intramuscular immunoglobulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intravenous immunoglobulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Immune globulin IM (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
flacon d'une solution injectable de 217 U d'immunoglobuline antihépatique B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human immunoglobulin g 10% injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
immunoglobuline humaine G, flacon de 10 g d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
immunoglobuline humaine G, flacon de 20 g d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human immunoglobulin g 5g liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
flacon de 1 unité d'immunoglobuline contre l'hépatite B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-tetanus immunoglobulin injection (procedure) |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human tick-borne encephalitis immunoglobulin injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Monoclonal component level (procedure) |
Component |
True |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum thyrotrophin binding inhibiting immunoglobulin level |
Component |
True |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Antilymphocyte immunoglobulin - chemical (substance) |
Is a |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mumps human immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hepatitis B surface antigen immunoglobulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytomegalovirus antibody-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antibody |
Is a |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Immunoglobulin structure (substance) |
Is a |
True |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Immunoglobulin allotype (substance) |
Is a |
True |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Respiratory syncytial virus immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
flacon d'une solution injectable de 250 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
flacon d'une solution pour perfusion de 2500 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
seringue préremplie avec solution injectable de 250 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Varicella-zoster virus antibody-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sérum d'immunoglobulines humaines |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vaccinia human immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing rabies human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing human tetanus immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pertussis human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing poliomyelitis human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antitetanus immunoglob. injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-varicella-zoster ig injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
immunoglobuline contre la rage de 150 UI/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
flacon d'une solution injectable de 150 U d'immunoglobuline contre la rage |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Immune globulin + sodium chloride 1gm/0.9%wv injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetanus immune globulin huma 250units injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetanus immune globulin huma 250units injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Complement and immunoglobulin measurement |
Component |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Human tick-borne encephalitis immunoglobulin injection solution 1 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human tick-borne encephalitis immunoglobulin injection solution 2 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human tick-borne encephalitis immunoglobulin injection solution 5 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human tick-borne encephalitis immunoglobulin injection solution 10 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
immunoglobuline humaine intraveineuse à 10% avec caprylate et purifiée par chromatographie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 500mg i-v infusion (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 2.5g i-v infusion (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 5g i-v infusion (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human normal immunoglobulin 10g i-v infusion (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Immunoglobulin radioimmunoassay (procedure) |
Component |
True |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Administration of Tetanus immune globulin, human |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intramuscular injection of human tetanus immunoglobulin |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-tetanus immunoglobulin injection (procedure) |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human immunoglobulin 1g nanofiltered powder for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human immunoglobulin 3g nanofiltered powder for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human immunoglobulin 6g nanofiltered powder for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human immunoglobulin 12g nanofiltered powder for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Botulism immunoglobulin (substance) |
Is a |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-rabies immunoglobulin injection |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intravenous injection of anticytomegalovirus immunoglobulin |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intravenous infusion of Rh immune globulin |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intramuscular injection of Rh immune globulin |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Administration of RhD immune globulin |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Human vaccinia immune globulin 50mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Injektion von RhD-Immunglobulin |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Anti-D globulin NOS |
Direct substance |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Human normal immunoglobulin 6g/50mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunoglobulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|